AA4500: Phase III halted

AUXL temporarily suspended dosing in a double-blind, placebo-controlled, Australian and Swiss Phase III trial of AA4500 to treat Dupuytren's

Read the full 193 word article

How to gain access

Continue reading with a
two-week free trial.